JP2017526651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526651A5 JP2017526651A5 JP2017503611A JP2017503611A JP2017526651A5 JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5 JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5
- Authority
- JP
- Japan
- Prior art keywords
- allulose
- less
- tablet
- dry weight
- compressible composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000008025 crystallization Effects 0.000 claims 4
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims 3
- 238000007907 direct compression Methods 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000000324 neuroprotective effect Effects 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 239000003642 reactive oxygen metabolite Substances 0.000 claims 1
- 230000002000 scavenging effect Effects 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306180.2 | 2014-07-21 | ||
| EP14306180 | 2014-07-21 | ||
| PCT/IB2015/001303 WO2016012854A1 (en) | 2014-07-21 | 2015-07-16 | Sugar compositions for tableting by direct compression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526651A JP2017526651A (ja) | 2017-09-14 |
| JP2017526651A5 true JP2017526651A5 (enExample) | 2018-08-23 |
| JP6803325B2 JP6803325B2 (ja) | 2020-12-23 |
Family
ID=51265636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017503611A Active JP6803325B2 (ja) | 2014-07-21 | 2015-07-16 | アルロースの製造方法及び錠剤の製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10342247B2 (enExample) |
| EP (1) | EP3171710B1 (enExample) |
| JP (1) | JP6803325B2 (enExample) |
| KR (1) | KR102501024B1 (enExample) |
| CN (1) | CN106535661B (enExample) |
| BR (1) | BR112017001192B1 (enExample) |
| CA (1) | CA2955849C (enExample) |
| CL (1) | CL2017000136A1 (enExample) |
| MX (1) | MX378866B (enExample) |
| SG (1) | SG11201700451QA (enExample) |
| WO (1) | WO2016012854A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017158534A (ja) * | 2016-03-07 | 2017-09-14 | 焼津水産化学工業株式会社 | チップ状食品の製造方法及びチップ状食品 |
| IL289910B2 (en) | 2016-10-28 | 2023-09-01 | Tate And Lyle Ingredients Americas Llc | A method for preparing allulose crystals |
| FR3061415B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops non cristallisables de d-allulose |
| FR3061413B1 (fr) * | 2017-01-05 | 2021-08-27 | Roquette Freres | Procede de fabrication de cristaux de d-allulose |
| FR3061414B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops cristallisables de d-allulose |
| CN106955290A (zh) * | 2017-03-24 | 2017-07-18 | 南京顺昌医药科技有限公司 | 一种治疗退化性疾病的组合物及其用途 |
| WO2019004554A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료의 제조방법 |
| KR101988442B1 (ko) | 2017-06-30 | 2019-06-12 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| WO2019004555A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| MX2020008430A (es) | 2018-02-12 | 2020-12-10 | Samyang Corp | Metodo para producir edulcorante cristalino funcional. |
| AU2020347662A1 (en) * | 2019-09-13 | 2022-03-31 | Meiji Co., Ltd. | Solid food and solid milk |
| EP3864966A1 (de) * | 2020-02-12 | 2021-08-18 | Savanna Ingredients GmbH | Orale zubereitungen mit kristalliner allulose |
| EP4000419A1 (de) | 2020-11-23 | 2022-05-25 | Savanna Ingredients GmbH | Trocknung von allulosekristallen |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT77919B (en) | 1983-01-07 | 1986-04-16 | Tate & Lyle Plc | Process for the production of solid fructose |
| US4692514A (en) | 1985-12-20 | 1987-09-08 | Uop Inc. | Process for separating ketoses from alkaline- or pyridine-catalyzed isomerization products |
| FI104787B (fi) | 1989-06-07 | 2000-04-14 | Xyrofin Oy | Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi |
| CN1221398A (zh) * | 1996-04-16 | 1999-06-30 | 拜尔公司 | 甘露糖醇及其制备 |
| FI110095B (fi) * | 1998-05-18 | 2002-11-29 | Xyrofin Oy | Ksylitolin kiteyttäminen, kiteinen ksylitolituote ja sen käyttö |
| JP4473980B2 (ja) | 1999-06-24 | 2010-06-02 | 株式会社林原生物化学研究所 | 糖質複合体結晶とその製造方法 |
| CN1668735A (zh) * | 2002-05-22 | 2005-09-14 | 国立大学法人香川大学 | 稀有糖的生物活性的利用方法及配合了稀有糖的组合物 |
| WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
| JP4761424B2 (ja) * | 2004-03-17 | 2011-08-31 | 株式会社希少糖生産技術研究所 | Ｌ−プシコース結晶、その製造方法および、糖試薬キット |
| GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| JP4873493B2 (ja) * | 2005-03-04 | 2012-02-08 | 国立大学法人 香川大学 | Ｄ−プシコースとｄ−アロースの糖質複合体結晶およびその製造方法 |
| JP5116071B2 (ja) * | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用 |
| KR101339443B1 (ko) | 2005-11-15 | 2013-12-06 | 가부시기가이샤하야시바라 | 케토오스 3-에피머라아제와 그 제조 방법 및 용도 |
| WO2008059623A1 (en) * | 2006-11-10 | 2008-05-22 | Matsutani Chemical Industry Co., Ltd. | Sweetener containing d-psicose and foods and drinks obtained by using the same |
| EP2156751B8 (en) | 2007-05-18 | 2018-11-14 | Matsutani Chemical Industry Co., Ltd. | Novel sweetener having sugar-like taste and production method and use of the same |
| WO2008148731A1 (de) | 2007-06-06 | 2008-12-11 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
| ES2686081T3 (es) | 2007-07-31 | 2018-10-16 | Cargill, Incorporated | Dextrosa comprimible directamente |
| CN100577793C (zh) * | 2007-12-12 | 2010-01-06 | 江南大学 | 微生物转化d-果糖制备d-阿洛酮糖的菌种和方法 |
| WO2010113785A1 (ja) * | 2009-03-30 | 2010-10-07 | 松谷化学工業株式会社 | 目的とするヘキソースを所定量含む原料糖とは異なる糖組成の糖組成物の製造方法および製造された糖組成物の用途 |
| KR101189640B1 (ko) | 2010-03-26 | 2012-10-12 | 씨제이제일제당 (주) | Ｄ-사이코스 결정을 제조하는 방법 |
| JP2011205913A (ja) | 2010-03-29 | 2011-10-20 | Kishoto Seisan Gijutsu Kenkyusho:Kk | 機能性異性化糖の複合体結晶糖質およびその製造方法 |
| JP5859191B2 (ja) * | 2010-09-29 | 2016-02-10 | 松谷化学工業株式会社 | 高甘味度甘味料に対する呈味改良組成物およびその応用 |
| JP6099870B2 (ja) * | 2012-01-06 | 2017-03-22 | 松谷化学工業株式会社 | スクロースとｄ−プシコースを含む新規甘味料 |
| CN102697744B (zh) | 2012-05-29 | 2013-11-27 | 安吉东来药用辅料有限责任公司 | 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN105188709A (zh) | 2013-04-26 | 2015-12-23 | 松谷化学工业株式会社 | 能量消耗的促进和/或能量消耗功能降低的治疗和/或预防剂、或者方法 |
| CN103333935A (zh) | 2013-05-24 | 2013-10-02 | 桐乡晟泰生物科技有限公司 | D-阿洛酮糖的生产工艺 |
-
2015
- 2015-07-16 JP JP2017503611A patent/JP6803325B2/ja active Active
- 2015-07-16 SG SG11201700451QA patent/SG11201700451QA/en unknown
- 2015-07-16 CA CA2955849A patent/CA2955849C/en active Active
- 2015-07-16 KR KR1020177000681A patent/KR102501024B1/ko active Active
- 2015-07-16 CN CN201580039823.8A patent/CN106535661B/zh active Active
- 2015-07-16 EP EP15778704.5A patent/EP3171710B1/en active Active
- 2015-07-16 BR BR112017001192-1A patent/BR112017001192B1/pt active IP Right Grant
- 2015-07-16 MX MX2017000827A patent/MX378866B/es unknown
- 2015-07-16 US US15/327,556 patent/US10342247B2/en active Active
- 2015-07-16 WO PCT/IB2015/001303 patent/WO2016012854A1/en not_active Ceased
-
2017
- 2017-01-18 CL CL2017000136A patent/CL2017000136A1/es unknown
-
2019
- 2019-05-29 US US16/425,014 patent/US20190289888A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526651A5 (enExample) | ||
| RU2015139758A (ru) | Хиназолины в качестве ингибиторов киназы | |
| JP2017178948A5 (enExample) | ||
| JP2016163571A5 (enExample) | ||
| FI3265084T3 (fi) | Brutonin tyrosiinikinaasin estäjän lääkeformulaatioita | |
| JP2012501986A5 (enExample) | ||
| JP2016540021A5 (enExample) | ||
| JP2010522242A5 (enExample) | ||
| CL2011000867A1 (es) | Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer. | |
| JP2016509051A5 (enExample) | ||
| JP2014221827A5 (enExample) | ||
| PH12017502325B1 (en) | Orodispersible dosage unit containing an estetrol component | |
| JP2009542678A5 (enExample) | ||
| JP2019510079A5 (enExample) | ||
| HK1244429A1 (zh) | 特别用於治疗注意力缺陷障碍的方法和组合物 | |
| JP2015537009A5 (enExample) | ||
| JP2016530291A5 (enExample) | ||
| JP2009541409A5 (enExample) | ||
| RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
| JP2014218523A5 (enExample) | ||
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| NO20090262L (no) | Galeniske formuleringer av aliskiren og hydroklorotiazid | |
| JP2015129124A5 (enExample) | ||
| JP2015129175A5 (enExample) | ||
| MX2010012019A (es) | Producto farmaceutico que comprende un antagonista receptor muscarinico y un agonista de adrenoceptor beta2. |